entertainment -WSS

entertainment

author：entertainment 2025-10-01 10:37:02 - browse：357

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The Pandemic Treaty must support building strong health systems

Wikipedia

WSS

US soldier in North Korean custody after crossing DMZ line

US soldier in North Korean custody after crossing DMZ line

Why you get paid to donate plasma but not blood

A look at other Americans who have crossed into North Korea over the years

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

focus

entertainment

hotspot

The high cost of giving birth even with insurance

BMI, flaws aside, is found to be useful estimate of body fat in youth

Duchenne breakthrough therapy leaves behind pioneering families

ASCO: Palliative care found as helpful given virtually as in person

Activists slam private health insurers over coverage restrictions

ER docs worry over extreme heat as a 'mass casualty event'

As demand for Covid shots wanes, Moderna seeks its next success

Biden administration sends mixed signals on US soldier who crossed into North Korea

23andMe had bad news about my health. I wish a person had delivered it

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

hotspot

Kaiser's Risant Health gobbled up Geisinger. Who is next?

HIV drugs protect against transmission, even in unprotected sex

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

With trial win, GSK could get blood cancer drug back on market

Shifting the focus from loneliness to social health

Ionis drug prevents swelling attacks due to hereditary angioedema

focus

Wikipedia

entertainment

hotspot